BICO has been awarded this year’s SwedenBIO Award for showcasing the power of the Swedish life-science industry on the global arena and its visionary business model and remarkable growth.

The bio convergence company, BICO, has received SwedenBIO’s Award which was announced in connection with SwedenBIO’s Annual Summit in Stockholm. Presented for the last fifteen years, the award honors a life science company that has shown outstanding achievements and contributions to society and that exemplifies the potential of a strong Swedish life science industry.

“We are incredibly honored to receive this award from SwedenBIO, an important and respected industry player,” says Erik Gatenholm, CEO and co-founder of BICO. “I am humbled and look forward to continue to develop our offering and contribute to enabling Health 4.0.”

“We hope that BICO can inspire Swedish companies”

Founded in 2016, BICO has quickly grown from being one company focused on bioinks and bioprinters to a global cohesive group of thirteen companies with an extensive range of bio convergence products and solutions enabling Health 4.0. BICO focuses on four Next Generation Core industrial eco systems; Tissue Engineering, Diagnostics, Multiomics and Cell Line Development.

”BICO has contributed to the good repute of the Swedish life science industry internationally and shown what can be achieved with a bold approach to market expansion. By presenting them with the SwedenBIO Award, we hope that BICO can inspire Swedish companies as they strive to take market shares in their respective areas,” says Mårten Steen, Managing Partner at HealthCap, who handed out the award onstage at the summit.

About the award

The SwedenBIO Award is the industry’s own award and is awarded in collaboration with HealthCap. Presented each year since 2007 it includes the distinction of the award, a floating trophy that changes hands annually with each new champion, and attendance at Nordic Life Science Days in Malmö in April 2022.

Photo of Erik Gatenholm: BICO